arrow
M

Massimo Martino

grande ospedale metropolitano bmm
H指数:30
被引数:3,337

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

更正:异基因造血干细胞移植后的继发性自身免疫性和炎症性疾病:来自EBMT移植并发症和自身免疫性疾病工作组的事后研究

2026-09-250
PRE
Real-world utilization of thrombopoietin receptor agonists in the italian hematopoietic stem cell transplantation setting: a comprehensive national survey by the Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO)

意大利造血干细胞移植背景下促血小板生成素受体激动剂的实际应用:Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) 开展的全面全国性调查

2026-09-180
PRE
Real-world approaches to preventing acute myeloid leukemia relapse after allogeneic transplantation: a national survey by GITMO (Gruppo Italiano Trapianto Midollo Osseo)

异基因移植后急性髓系白血病复发的预防策略:GITMO(意大利骨髓移植组)全国调查

2026-08-050
PRE
Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties

异基因造血干细胞移植后的继发性自身免疫性和炎症性疾病:来自EBMT移植并发症和自身免疫性疾病工作组的事后研究

2026-07-270
PRE
Allogeneic hematopoietic cell transplantation from haploidentical donors with total body irradiation versus chemo-based regimens for adult AML patients in first complete remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT)
2026-07-200
PRE
Allogeneic stem cell transplantation in adult Ph-like acute lymphoblastic leukemia. Results from two consecutive GIMEMA protocols
2026-07-080
OA
Outcomes of CAR T-Cell Therapy in Transformed Indolent Non-Hodgkin Lymphomas and de novo DLBCL: a comparative analysis from the Italian CAR T-SIE study

CAR T细胞疗法在转化型惰性非霍奇金淋巴瘤和原发型DLBCL中的疗效:来自意大利CAR T-SIE研究的比较分析

2026-06-130
PRE
Polatuzumab vedotin–containing regimens as bridge to CART: analysis from the CART-SIE study

Polatuzumab vedotin-含方案作为桥接CART:CART-SIE研究分析

2026-05-070
OA
Treosulfan-based double-alkylator conditioning in myelofibrosis: An Italian retrospective multicenter analysis

曲奥舒凡为基础的双烷化剂预处理方案在骨髓纤维化中的应用:一项意大利多中心回顾性分析

2025-12-260
PRE
Efficacy of Polyvinylpyrrolidone–Zinc Gluconate and Taurine Gel in the Prophylaxis of Oral Mucositis in Adults Undergoing High-Dose Chemotherapy and Allogeneic Stem Cell Transplantation

聚乙烯吡咯烷酮-葡萄糖酸锌和牛磺酸凝胶在预防接受高剂量化疗和同种异体干细胞移植的成人口腔黏膜炎中的疗效

2025-12-190
OAAI
Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia

更正:CPX-351在60岁以下继发急性髓系白血病患者中的真实世界多中心疗效分析

2025-12-040
OAAI
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study

移植物抗宿主病流行病学、预防和管理趋势:意大利骨髓移植、造血干细胞和细胞治疗小组(GITMO)GVHD24研究

2025-11-010
PRE